June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
A Case-Control Study of Herpes Zoster Ophthalmicus: Bronx Epidemiology of HIV Eye Studies (BEHIVES)
Author Affiliations & Notes
  • Marianna Atiya
    Albert Einstein College of Medicine, Bronx, NY
  • David Poulsen
    Albert Einstein College of Medicine, Bronx, NY
  • Ethan K Sobol
    Albert Einstein College of Medicine, Bronx, NY
  • Grace Honik
    Ophthalmology and Visual Sciences, Montefiore Medical Center, Bronx, NY
  • Jose Diaz
    Albert Einstein College of Medicine, Bronx, NY
  • Jonathan Powell
    Ophthalmology and Visual Sciences, Montefiore Medical Center, Bronx, NY
  • David C Gritz
    Albert Einstein College of Medicine, Bronx, NY
    Ophthalmology and Visual Sciences, Montefiore Medical Center, Bronx, NY
  • Footnotes
    Commercial Relationships Marianna Atiya, None; David Poulsen, None; Ethan Sobol, None; Grace Honik, None; Jose Diaz, None; Jonathan Powell, None; David Gritz, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 5754. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Marianna Atiya, David Poulsen, Ethan K Sobol, Grace Honik, Jose Diaz, Jonathan Powell, David C Gritz; A Case-Control Study of Herpes Zoster Ophthalmicus: Bronx Epidemiology of HIV Eye Studies (BEHIVES). Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):5754.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Herpes zoster ophthalmicus (HZO) has an estimated incidence of 1.5 to 6.4 cases per 100,000 persons per year in the general population. The purpose of this retrospective case-control study is to examine the risk of developing HZO among patients who are positive for human immunodeficiency virus (HIV), and among patients with history of atopic disease.

Methods: This study utilized hospital-based controls for the study period from May 1, 2006 to May 31, 2014. Inclusion criteria involved Bronx residents diagnosed with new-onset HZO during the eight-year study period at Montefiore Medical Center. Hospital-based controls were drawn from unique outpatients visits at Montefiore Medical Center during the study period. Controls were chosen randomly in a 4:1 ratio and were time-matched to HZO cases. Medical records were reviewed to confirm inclusion criteria and the data were used to calculate odds ratios for developing HZO in HIV-positive patients and in patients with history of atopic disease.

Results: 170 patients were diagnosed with new-onset HZO during the study period. Compared to hospital-based controls (n=680), HIV infection was shown to increase the odds of HZO by 6.63 (95% CI 2.96-14.8, p<0.001), and history of atopic disease was shown to increase the odds of HZO by 2.55 (95% CI 1.50-4.37, p=0.001).

Conclusions: Infection with HIV and history of atopic disease are significant risk factors for having a new-onset case of HZO. This is a particularly important association in the Bronx, where the prevalence of HIV infection is over 3.6 times greater than in the United States overall.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×